Proteomics Intl Labs Ltd has released a press release.
June 2024 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Eurobio Scientific to sell PromarkerD DKD test in France
- Proteomics appoints medical devices sales agency for Europe
- March 2024 Quarterly Activities Report and Appendix 4C
- Proteomics signs with Oxford Univ to validate test for Endo
- PromarkerD US commercialisation & Promarker pipeline update
Later from Proteomics International Laboratories
- Groundbreaking results for type 1 diabetes and kidney health
- Update on commercialisation of PromarkerD in the USA
- Esophageal cancer diagnostic delivers excellent results
- September 2024 Quarterly Activities Report and Appendix 4C
- AGM Chairman's Address and Investor Presentation
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories